Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
- Conditions
- Schizophrenia
- Registration Number
- NCT00063297
- Brief Summary
This study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms of schizophrenia in adults.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 180
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (28)
Birmingham Psychiatry Pharmaceutical Studies, Inc.
🇺🇸Birmingham, Alabama, United States
IPR
🇺🇸Cerritos, California, United States
Synergy Clinical Research
🇺🇸Chula Vista, California, United States
Optimum Health Services
🇺🇸La Mesa, California, United States
Sierra Vista Hospital
🇺🇸Sacramento, California, United States
Clinical Innovations
🇺🇸Santa Ana, California, United States
Research Strategies
🇺🇸Torrance, California, United States
University of Colorado
🇺🇸Denver, Colorado, United States
Psychiatric Institute of Washington
🇺🇸Washington, DC, District of Columbia, United States
Berma Research Group
🇺🇸Hialeah, Florida, United States
Scroll for more (18 remaining)Birmingham Psychiatry Pharmaceutical Studies, Inc.🇺🇸Birmingham, Alabama, United States